VisiFlora vs AREDS2, Explained
AREDS2 is a specific, clinically studied nutrient formulation from a National Eye Institute clinical trial for people with intermediate or advanced age-related macular degeneration.
VisiFlora uses some of the same ingredient names, but the amounts and evidence base are meaningfully different.
What AREDS2 actually is
AREDS2 refers to a specific formulation studied in a large, randomized clinical trial run by the National Eye Institute, intended for people who already have intermediate or advanced AMD in at least one eye.
Where VisiFlora's disclosed amounts fall short
Where the comparison can't even be made
Lutein and zeaxanthin amounts are hidden inside VisiFlora's 351mg proprietary blend, so there's no way to compare those two carotenoids against the defined amounts AREDS2 used at all.
Why this distinction matters for you
AREDS2 guidance is intended for a specific, clinically diagnosed population under a doctor's care. A general-market vision supplement sharing some ingredient names is not interchangeable with that clinically studied formulation, regardless of how the product is marketed.
Applying this to VisiFlora
If you have diagnosed AMD or another eye condition, discuss AREDS2 or AREDS2-equivalent options directly with your eye-care professional rather than substituting VisiFlora or any general vision supplement.
